Nath Bio-Genes (I)

Nath Bio-Genes (I) FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Nath Bio-Genes (I) (NATHBIOGEN.NS) as of Oct 29, 2026 is -60.15 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 25.03 % — a change of -340.32% (lower).

FCF Conversion

-60.15 %

YoY

-340.32%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Nath Bio-Genes (I) is 2026 -60.15 % . FCF Conversion Rate (FCF/EBITDA) of Nath Bio-Genes (I) was 2025 25.03 % . It decreases by -340.32% lower compared to the previous year.

The Nath Bio-Genes (I) FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2019
-115.22 INR
Jan 1, 2020
-13.33 INR
Jan 1, 2021
-18.84 INR
Jan 1, 2022
5.90 INR
Jan 1, 2023
102.30 INR
Jan 1, 2024
134.00 INR
Jan 1, 2025
25.03 INR
Jan 1, 2026
-60.15 INR
The Nath Bio-Genes (I) FCF Conversion history
YEARFCF ConversionYoY
-60.15 %-340.32%
25.03 %-81.32%
134.00 %+30.98%
102.30 %+1,635.12%
5.90 %-131.30%
-18.84 %+41.33%
-13.33 %-88.43%
-115.22 %-34.62%
-176.22 %+3,567.31%
-4.81 %-98.10%
-252.59 %-1,160.45%
23.82 %-52.29%
49.92 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Nath Bio-Genes (I) Stock analysis

What does Nath Bio-Genes (I) do? Nath Bio-Genes (I) is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Nath Bio-Genes (I) stock

FCF Conversion Rate (FCF/EBITDA) of Nath Bio-Genes (I) is -60.15 % in 2026.

FCF Conversion Rate (FCF/EBITDA) of Nath Bio-Genes (I) changed from 25.03 % to -60.15 %, representing a -340.32% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Nath Bio-Genes (I) since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Nath Bio-Genes (I) with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — Nath Bio-Genes (I)

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Nath Bio-Genes (I)